Position in ATYR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$123,858
-$112,917 QoQ
Shares Held
207,468
-31.7% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#22
of 90 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ATYR ranks #304 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ATYR
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,858 | 207,468 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $236,775 | 303,559 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $99,205 | 126,700 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $128,099 | 177,671 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $214,693 | 42,346 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $870,699 | 288,311 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $330,230 | 91,224 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,091 | 620 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $182,577 | 117,037 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $304,541 | 156,175 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $209,749 | 148,759 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $183 | 116 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,203 | 1,483 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $140 | 64 | Shares | Defined | 2023-02-10 | |
| 2021-09-30 | $3,468 | 382 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,464 | 300 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $178 | 40 | Shares | Defined | 2021-05-14 | |
| 2020-03-31 | $3,074 | 1,098 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||